Table of contents
Volume 85, Issue 12
Published online 11 December 2001 (1813-2039)
Regular Articles
Activation and activities of the p53 tumour suppressor protein FREE
É Bálint and K H Vousden
Br J Cancer 85: 1813-1823; doi:10.1054/bjoc.2001.2128
The surgical management of women with ovarian cancer in the south west of England FREE
A Olaitan, J Weeks, A Mocroft, J Smith, K Howe and J Murdoch
Br J Cancer 85: 1824-1830; doi:10.1054/bjoc.2001.2196
Papillary thyroid carcinoma: 6 cases from 2 families with associated lymphocytic thyroiditis harbouring RET/PTC rearrangements FREE
C Mechler, A Bounacer, H Suarez, M Saint Frison, C Magois, G Aillet and A Gaulier
Br J Cancer 85: 1831-1837; doi:10.1054/bjoc.2001.2187
Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer FREE
R Torrisi, L Baglietto, H Johansson, G Veronesi, B Bonanni, A Guerrieri-Gonzaga, B Ballardini and A Decensi
Br J Cancer 85: 1838-1841; doi:10.1054/bjoc.2001.2191
Validating automated screening for psychological distress by means of computer touchscreens for use in routine oncology practice FREE
A Cull, A Gould, A House, A Smith, V Strong, G Velikova, P Wright and P Selby
Br J Cancer 85: 1842-1849; doi:10.1054/bjoc.2001.2182
Pilot study with pegylated liposomal doxorubicin for advanced or unresectable hepatocellular carcinoma FREE
M Schmidinger, C Wenzel, G J Locker, F Muehlbacher, R Steininger, M Gnant, R Crevenna and A C Budinsky
Br J Cancer 85: 1850-1852; doi:10.1054/bjoc.2001.2149
Evaluation of nurse-led follow up for patients undergoing pelvic radiotherapy FREE
S Faithfull, J Corner, L Meyer, R Huddart and D Dearnaley
Br J Cancer 85: 1853-1864; doi:10.1054/bjoc.2001.2173
A phase II trial of marimastat in advanced pancreatic cancer FREE
J D Evans, A Stark, C D Johnson, F Daniel, J Carmichael, J Buckels, C W Imrie, P Brown and J P Neoptolemos
Br J Cancer 85: 1865-1870; doi:10.1054/bjoc.2001.2168
Biochemotherapy of metastatic malignant melanoma. Predictive value of tumour-infiltrating lymphocytes FREE
A Håkansson, B Gustafsson, L Krysander, B Hjelmqvist, B Rettrup and L Håkansson
Br J Cancer 85: 1871-1877; doi:10.1054/bjoc.2001.2169
Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer FREE
G Nicoll, D N Crichton, H E McDowell, N Kernohan, T R Hupp and A M Thompson
Br J Cancer 85: 1878-1882; doi:10.1054/bjoc.2001.2163
Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies FREE
C Moch, A Moysan, R Lubin, P de La Salmonière, N Soufir, F Galisson, C Vilmer, E Venutolo, F Le Pelletier, A Janin and N Basset-Séguin
Br J Cancer 85: 1883-1886; doi:10.1054/bjoc.2001.2185
Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder FREE
F Kimura, A R Florl, H-H Seifert, J Louhelainen, S Maas, M A Knowles and W A Schulz
Br J Cancer 85: 1887-1893; doi:10.1054/bjoc.2001.2154
Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder FREE
J Edwards, P Duncan, J J Going, K M Grigor, A D Watters and J M S Bartlett
Br J Cancer 85: 1894-1899; doi:10.1054/bjoc.2001.2159
Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma FREE
T Stokke, P DeAngelis, L Smedshammer, E Galteland, H B Steen, E B Smeland, J Delabie and H Holte
Br J Cancer 85: 1900-1913; doi:10.1054/bjoc.2001.2164
relA over-expression reduces tumorigenicity and activates apoptosis in human cancer cells FREE
A Ricca, A Biroccio, D Trisciuoglio, M Cippitelli, G Zupi and D Del Bufalo
Br J Cancer 85: 1914-1921; doi:10.1054/bjoc.2001.2174
RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer FREE
T Oshikiri, Y Hida, M Miyamoto, H Hashida, K Katoh, M Suzuoki, Y Nakakubo, K Hiraoka, T Shinohara, T Itoh, S Kondo and H Katoh
Br J Cancer 85: 1922-1927; doi:10.1054/bjoc.2001.2192
Expression of RAC 3, a steroid hormone receptor co-activator in prostate cancer FREE
V J Gnanapragasam, H Y Leung, A S Pulimood, D E Neal and C N Robson
Br J Cancer 85: 1928-1936; doi:10.1054/bjoc.2001.2179
Nuclear thymidylate synthase expression, p53 expression and 5FU response in colorectal carcinoma FREE
N A C S Wong, L Brett, M Stewart, A Leitch, D B Longley, M G Dunlop, P G Johnston, A M Lessells and D I Jodrell
Br J Cancer 85: 1937-1943; doi:10.1054/bjoc.2001.2175
Human melanoma cells inhibit the earliest differentiation steps of human Langerhans cell precursors but failed to affect the functional maturation of epidermal Langerhans cells FREE
O Berthier-Vergnes, M Gaucherand, J Péguet-Navarro, J Plouet, J-F Pageaux, D Schmitt and M-J Staquet
Br J Cancer 85: 1944-1951; doi:10.1054/bjoc.2001.2183
Nipple aspirate cytology and pathologic parameters predict residual cancer and nodal involvement after excisional breast biopsy FREE
E R Sauter, H Ehya, A Mammen and Gary Klein
Br J Cancer 85: 1952-1957; doi:10.1054/bjoc.2001.2151
E-cadherin as a prognostic indicator in primary breast cancer FREE
C Parker, R S Rampaul, S E Pinder, J A Bell, P M Wencyk, R W Blamey, R I Nicholson, J F R Robertson and I O Ellis
Br J Cancer 85: 1958-1963; doi:10.1054/bjoc.2001.2178
Topical administration of a doxorubicin-specific monoclonal antibody prevents drug-induced mouth apoptosis in mice FREE
A Balsari, C Rumio, D Morelli, L Sfondrini, E Nardini, I Barajon and S Ménard
Br J Cancer 85: 1964-1967; doi:10.1054/bjoc.2001.2188
Uptake of IgG in osteosarcoma correlates inversely with interstitial fluid pressure, but not with interstitial constituents FREE
C de Lange Davies, B Ø Engesæter, I Haug, I W Ormberg, J Halgunset and C Brekken
Br J Cancer 85: 1968-1977; doi:10.1054/bjoc.2001.2180
Demonstration of mixed properties of RU486 in progesterone receptor (PR)-transfected MDA-MB-231 cells: a model for studying the functions of progesterone analogues FREE
V C-L Lin, S E Aw, E H Ng, E H-L Ng and M G-K Tan
Br J Cancer 85: 1978-1986; doi:10.1054/bjoc.2001.2167
Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion FREE
E V Batrakova, S Li, W F Elmquist, D W Miller, V Y Alakhov and A V Kabanov
Br J Cancer 85: 1987-1997; doi:10.1054/bjoc.2001.2165
Selective modulation of P-glycoprotein-mediated drug resistance FREE
M Bebawy, M B Morris and B D Roufogalis
Br J Cancer 85: 1998-2003; doi:10.1054/bjoc.2001.2184
Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat FREE
F Ponthan, P Kogner, P Bjellerup, L Klevenvall and M Hassan
Br J Cancer 85: 2004-2009; doi:10.1054/bjoc.2001.2186
Effect of VEGF receptor inhibitor PTK787/ZK222548 combined with ionizing radiation on endothelial cells and tumour growth FREE
C Hess, V Vuong, I Hegyi, O Riesterer, J Wood, D Fabbro, C Glanzmann, S Bodis and M Pruschy
Br J Cancer 85: 2010-2016; doi:10.1054/bjoc.2001.2166
Tyrphostin AG 1024 modulates radiosensitivity in human breast cancer cells FREE
B Wen, E Deutsch, E Marangoni, V Frascona, L Maggiorella, B Abdulkarim, N Chavaudra and J Bourhis
Br J Cancer 85: 2017-2021; doi:10.1054/bjoc.2001.2171
Calendar
Top of pageErratum
Profile of a differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line FREE
Br J Cancer 85: 2023-2025; doi:10.1054/bjoc.2001.2199
Author index to Volume 85
Top of pageKeyword index to Volume 85
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
